Evidence map›Paper›PMID 25137062›Full record

ArticlePloS one2014

The IκB kinase complex is required for plexin-B-mediated activation of RhoA.

Matthias Zielonka, Ramesh K Krishnan, Jakub M Swiercz, Stefan Offermanns

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Matthias ZielonkaMax-Planck-Institute for Heart and Lung Research, Department of Pharmacology, Bad Nauheim, Germany; Institute of Pharmacology, University of Heidelberg, Heidelberg, Germany.
Ramesh K KrishnanMax-Planck-Institute for Heart and Lung Research, Department of Pharmacology, Bad Nauheim, Germany.
Jakub M SwierczMax-Planck-Institute for Heart and Lung Research, Department of Pharmacology, Bad Nauheim, Germany.
Stefan OffermannsMax-Planck-Institute for Heart and Lung Research, Department of Pharmacology, Bad Nauheim, Germany; Medical Faculty, University of Frankfurt, Frankfurt am Main, Germany.
Max Planck Institute for Heart and Lung Research · DEGoethe University Frankfurt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plexins are widely expressed transmembrane proteins that mediate the cellular effects of semaphorins. The molecular mechanisms of plexin-mediated signal transduction are still poorly understood. Here we show that signalling via B-family plexins leading to the activation of the small GTPase RhoA requires activation of the IκB kinase (IKK)-complex. In contrast, plexin-B-dependent regulation of R-Ras activity is not affected by IKK activity. This regulation of plexin signalling depends on the kinase activity of the IKK-complex, but is independent of NF-κB activation. We confirm that the IKK-complex is active in tumour cells and osteoblasts, and we demonstrate that plexin-B-dependent tumour cell invasiveness and regulation of osteoblast differentiation require an active IKK-complex. This study identifies a novel, NF-κB-independent function of the IKK-complex and shows that IKK directs plexin-B signalling to the activation of RhoA.

Indexed as

Cell Adhesion MoleculesCell DifferentiationCell LineCell Line, TumorHEK293 CellsHumansI-kappa B KinaseMCF-7 CellsNerve Tissue ProteinsNF-kappa BrhoA GTP-Binding ProteinSignal TransductionCell Adhesion MoleculesI-kappa B KinaseNerve Tissue ProteinsNF-kappa BplexinrhoA GTP-Binding Protein

Identifiers

PMID25137062
PMCPMC4138210
OpenAlexW2100311457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.